Black Diamond Therapeutics Inc（BDTX）價格預測BDTXBlack Diamond Therapeutics Inc

Alphio's BDTX stock price prediction model matches the current Black Diamond Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.71 (-0.97%). The 1-week path is $1.74 (+0.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Black Diamond Therapeutics Inc is not a strong buy right now due to its current price of $1.73, which is significantly below its 52-week high of $4.94, indicating a potential for recovery but also substantial risk. The RSI is at 44.048, suggesting it is nearing oversold territory but not yet a strong buy signal. Additionally, the forward P/E ratio of 8.33 indicates potential undervaluation, but the recent 35.8% drop in stock price due to mixed clinical trial results raises concerns about its near-term prospects.

Black Diamond Therapeutics Inc (BDTX) last closed at $1.73, gaining +4.22%. These facts feed the 1-day and 1-week BDTX price prediction above.